Michel G, Pfeiffer F, Duvillard P, Prade M, Castaigne D, Zarca D, Pejovic-Lenfant M H, Gerbaulet A, Lhomme C
Département de Chirurgie oncologique, Institut Gustave-Roussy, Villejuif.
J Gynecol Obstet Biol Reprod (Paris). 1989;18(8):1024-30.
From 1970 to 1987 fifty patients with uterine sarcoma who have been operated at the G. Roussy Institute (IGR) were studied. The histological material was reviewed according to the W.H.O. classification and the Hendrickson and Kempson's criteria. Staging was done on surgical and histological findings according to the pTNM classification of the UICC for endometrial carcinoma. There were 22 cases of heterologous malignant mixed müllerian tumor (MMT), 5 cases of homologous MMT, 20 cases of leiomyosarcoma (LS), 1 high grade stromal sarcoma, 1 low grade stromal sarcoma (stromal myosis (SM], 1 adenosarcoma. There were 22 cases of stage T1 T2, 23 cases of stage T3 T4 and 5 TX (first surgery outside IGR). Total hysterectomy with bilateral salpingo-oophorectomy was performed in 86% of the cases. Radiation therapy was performed in 26 cases mostly external pelvic irradiation associated with endobrachytherapy. "Cyvadic" combination chemotherapy was used in 16 cases associated with platinum in few cases. There were 2 postoperative deaths, 11 cases of progression and 37 cases of complete remission (CR). Of the 37 cases of CR, 10 patients are alive with NED 6 months to 10 years after diagnosis in 2 cases of MMT. 27 patients presented recurrence or metastasis. Of the 22 patients with pelvi-abdominal recurrence, 10 had debulking surgery (one total pelvic exenteration (PE), three posterior PE). Among them five are alive 14 to 78 months later (3 LS, 1 AS, 1 SM). Thirty percent of the patients developed lung metastasis. The overall five-year survival was 42 +/- 16% (28 patients) (Kaplan-Meier's method), similar to literature data.(ABSTRACT TRUNCATED AT 250 WORDS)
1970年至1987年,对在古斯塔夫·鲁西研究所(IGR)接受手术的50例子宫肉瘤患者进行了研究。根据世界卫生组织(WHO)分类以及亨德里克森和肯普森的标准对组织学材料进行了复查。根据国际抗癌联盟(UICC)针对子宫内膜癌的pTNM分类,依据手术和组织学检查结果进行分期。其中有22例异源性恶性混合苗勒管肿瘤(MMT)、5例同源性MMT、20例平滑肌肉瘤(LS)、1例高级别间质肉瘤、1例低级别间质肉瘤(间质肌瘤[SM])、1例腺肉瘤。有22例处于T1 T2期,23例处于T3 T4期,5例为TX期(首次手术在IGR以外进行)。86%的病例实施了全子宫切除术及双侧输卵管卵巢切除术。26例患者接受了放射治疗,多数为盆腔外照射联合腔内近距离放疗。16例患者使用了“Cyvadic”联合化疗,少数病例联合使用了铂类药物。术后有2例死亡,11例病情进展,37例完全缓解(CR)。在37例CR患者中,10例患者在诊断后6个月至10年无疾病证据(NED)存活,其中2例为MMT。27例患者出现复发或转移。在22例盆腔腹部复发患者中,10例接受了减瘤手术(1例全盆腔脏器切除术[PE],3例后路PE)。其中5例在14至78个月后存活(3例LS,1例AS,1例SM)。30%的患者发生了肺转移。总体五年生存率为42±16%(28例患者)(采用Kaplan-Meier法),与文献数据相似。(摘要截取自250字)